| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |